Navigating Intensive Chemotherapy in the Community Setting

Author(s):

Margaret T. Kasner, MD,Christian Fidler, MD

Panelists discuss how community settings face unique challenges in delivering intensive chemotherapy regimens for secondary AML, including limited resources and expertise, but can implement best practices and leverage potential benefits of community-based care to provide effective treatment.

EP: 1.Implementing Updates to AML Classification Guidelines

EP: 2.Treatment Goals in Secondary AML

EP: 3.The Role of Molecular and Cytogenetic Testing in Secondary AML

EP: 4.Patient-Centered Decision-Making in Secondary AML Treatment

EP: 5.Assessing Transplant Eligibility and Fitness for Intensive Chemotherapy

EP: 6.Evidence-Based Approaches to Intensive Chemotherapy in Secondary AML

Now Viewing

EP: 7.Navigating Intensive Chemotherapy in the Community Setting

EP: 8.Optimizing AML Care Through Academic-Community Collaboration

EP: 9.Practice Pearls for Treatment of Secondary AML in the Community Setting

Video content above is prompted by the following:

In the community setting, what are some of the unique challenges faced in delivering intensive chemotherapy regimens?
- What are best practices you/your practice have implemented to mitigate these challenges?
Please describe some of the potential benefits of treating a patient in the community setting or in the outpatient setting with intensive induction (e.g., CPX-351).